Impact Events
MoreDate | Lead Company | Event | Type | Approval Change | Approval Likelihood |
---|---|---|---|---|---|
7/1/22 | Endo International (ENDP) | Xiaflex for Frozen Shoulder Syndrome (Adhesive Capsulitis) | Subscribers Only | Subscribers Only | Subscribers Only |
6/30/22 | 9 Meters Biopharma (NMTR) | Vurolenatide for Short Bowel Syndrome (SBS) | Subscribers Only | Subscribers Only | Subscribers Only |
6/29/22 | Can-Fite BioPharma (CANF) | Piclidenoson for Psoriasis | Subscribers Only | Subscribers Only | Subscribers Only |
6/25/22 | GSK (GSK) | Bepirovirsen for Hepatitis B (HBV) Treatment (Antiviral) | Subscribers Only | Subscribers Only | Subscribers Only |
6/22/22 | Galderma | Nemolizumab for Pruritus | Subscribers Only | Subscribers Only | Subscribers Only |
Upcoming Catalysts
MoreExpected Date Range | Lead Company | Drug | Expected Catalyst |
---|---|---|---|
07/07/22 | Subscribers Only | Subscribers Only | Regulatory - PDUFA for sNDA/sBLA |
07/09/22 | Subscribers Only | Subscribers Only | Trial Data - Other |
07/10/22 | Subscribers Only | Subscribers Only | Trial Data - Top-Line Results |
07/11/22 | Subscribers Only | Subscribers Only | Trial Data - Final Results |
07/11/22 | Subscribers Only | Subscribers Only | Trial Data - Top-Line Results |